Assisted Reproductive Technology Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Assisted Reproductive Technology Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The assisted reproductive technology market has demonstrated robust growth in recent years. Its valuation is predicted to rise from $37.06 billion in 2025 to $40.46 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.2%. This past growth can be ascribed to several factors, including an increase in infertility prevalence, the observed trends of increasing maternal age, the expansion of fertility clinics, the wider availability of assisted reproductive procedures, and the growing social acceptance of ART treatments.
The assisted reproductive technology market is projected to experience robust expansion over the coming years. Its value is anticipated to reach $56.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This expansion throughout the forecast period stems from factors such as the greater acceptance of precision fertility diagnostics, augmented investments in fertility treatment infrastructure, broader applications of genetic testing, an increasing need for minimally invasive procedures, and enhanced healthcare expenditures directed towards reproductive health. Key trends identified for the forecast period encompass a surge in the embrace of advanced embryo screening methodologies, a rise in the utilization of frozen embryo and egg banking, an escalating demand for customized fertility treatments, the widening scope of genetic testing within ART procedures, and a heightened emphasis on the efficacy of treatments.
Get A Free Sample Report With In-Depth Market Insights:
Assisted Reproductive Technology Market Growth Factors Behind Sustained Expansion
The increasing prevalence of infertility cases is anticipated to fuel the assisted reproductive technology market in the coming years. Infertility is defined as the inability to conceive after a year of consistent, unprotected sexual intercourse. This condition affects both men and women, typically diagnosed by a failure to achieve pregnancy. Assisted reproductive technology (ART) is utilized to treat infertility, encompassing fertility treatments that involve both a woman’s egg and a man’s sperm. For instance, in April 2023, the World Health Organization (WHO), an international public health organization based in Switzerland, indicated that millions of reproductive-aged individuals worldwide contend with infertility, which also impacts their families and communities. Globally, an estimated 1 in 6 adults, or roughly 17.5% of the global adult population, experience infertility. Thus, the rising incidence of infertility cases acts as a key driver for the growth of the assisted reproductive technology market.
Assisted Reproductive Technology Market Segment Performance And Emerging Opportunities
The assisted reproductive technology market covered in this report is segmented –
1) By Diagnosis: Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing
2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking
3) By End-User: Hospitals, Fertility Clinics, Other End-Users
Subsegments:
1) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG)
2) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound
3) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing
Assisted Reproductive Technology Market Industry Trends Fueling Future Revenue Growth
Leading companies within the assisted reproductive technology market are concentrating on developing advanced solutions, such as next-generation sequencing (NGS)-based testing kits, to enhance chromosomal analysis, improve embryo selection, and boost the success rates of fertility treatments. NGS-based preimplantation genetic testing refers to research-use technologies that facilitate a comprehensive evaluation of chromosomal abnormalities in embryos, thereby supporting informed decision-making during IVF and ICSI procedures. For instance, in July 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, unveiled two next-generation sequencing-powered products: the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, both designed to support preimplantation genetic testing for aneuploidy (PGT-A). Developed for reproductive health laboratories, these assays are the pioneering research-use products of their kind and are compatible with the Ion Torrent Genexus Integrated Sequencer, enabling a streamlined workflow from sample processing to aneuploidy analysis. PGT-A testing aids in identifying chromosomal abnormalities in embryo samples, and these new solutions aim to advance scientific understanding, improve pregnancy success rates, and foster healthier outcomes for future generations. The Genexus platform further simplifies the research process through integrated templating, sequencing, and data analysis, while the Ion AmpliSeq Polyploidy Panel kit offers enhanced quality control features to detect contamination, avoid sample mix-ups, and identify triploidy in embryos, reinforcing technological progress within the assisted reproductive technology market.
Assisted Reproductive Technology Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the assisted reproductive technology market are Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois
View The Full Assisted Reproductive Technology Market Report:
Assisted Reproductive Technology Market Geographic Landscape: Which Region Leads Industry Growth?
Europe was the largest region in the assisted reproductive technology market in 2025. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
